Table 2 Local control and overall survival according to stage and chemotherapy regimen
Characteristics | Total | TS | PF | p value |
|---|---|---|---|---|
Stage II | N = 50 | N = 28 | N = 22 | |
5-year LC | 60.1% | 64.8% | 53.9% | 0.526 |
5-year OS | 35.7% | 40.5% | 32.4% | |
Median survival | 32.1 months | 30.8 months | 35.1 months | 0.855 |
Stage III | N = 90 | N = 26 | N = 64 | |
5-year LC | 53.3% | 56.6% | 49.6% | 0.244 |
5-year OS | 32.3% | 47.1% | 25.9% | |
Median survival | 24.0 months | 42.4 months | 14.6 months | 0.015 |
Total | N = 140 | |||
5-year LC | 55.9% | 61.2% | 51.1% | 0.185 |
5-year OS | 33.4% | 44.3% | 27.4% | |
Median survival | 29.5 months | 37.7 months | 18.6 months | 0.025 |